About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 934 entries already.
Entries by Max
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Newsletter 46/2026 November 15, 2026
- Phase 2 Trial: Deruxtecan in Neuroendocrine Prostate Cancer November 13, 2026
- UPDATE: First Patient Treated With ICP-B381, a Dual-Target PSMA/STEAP1 Antibody-Drug Conjugate November 13, 2026
- UPDATE: FDA Grants Breakthrough Therapy Designation to ⁶⁴Cu-SAR-bisPSMA for Prostate Cancer Imaging November 13, 2026
